A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia
Clinical trial NCT05597020 · COMPLETED
Trial details
- NCT number
- NCT05597020
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-16
- Primary completion
- 2024-04-12
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.